Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 3

Risk Factors For Agressive Posterior Retinopathy of Prematurity

Agresif Posterior Prematüre Retinopatisi Risk Faktörleri

Pages
195–198
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is difficult to decide whether other statistically significant risk factors including APGAR 1 and 5 scores, need for blood transfusion, respiratory distress syndrome and clinical sepsis are independent risk factors or accompanying diseases related to prematurity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To establish risk factors for agressive posterior retinopathy of prematurity (APROP) by investigating clinical and demographical characteristics of premature infants who were treated with laser photocoagulation for retinopathy of prematurity (ROP).Materials and Methods: Medical records of premature infants who were treated with transpupillary diode laser photocoagulation were reviewed for gestational age, birthweight, APGAR 1 and 5 scores, mode of delivery, sex, multiple pregnancy, preeclampsia, maternal diabetes, early membrane rupture, ablatio placenta, blood transfusion, clinical sepsis, respiratory distress syndrome, necrotizing enterocolitis, intracranial hemorrhage, hydrocephalus and in-vitro fertilisation.
📊
Key Findings & Data:The infants who were treated for threshold or high-risk prethreshold ROP were categorized in group 1 and those with APROP were in group 2.
💡
Conclusion & Impact:It is difficult to decide whether other statistically significant risk factors including APGAR 1 and 5 scores, need for blood transfusion, respiratory distress syndrome and clinical sepsis are independent risk factors or accompanying diseases related to prematurity
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To establish risk factors for agressive posterior retinopathy of prematurity (APROP) by investigating clinical and demographical characteristics of premature infants who were treated with laser photocoagulation for retinopathy of prematurity (ROP).Materials and Methods: Medical records of premature infants who were treated with transpupillary diode laser photocoagulation were reviewed for gestational age, birthweight, APGAR 1 and 5 scores, mode of delivery, sex, multiple pregnancy, preeclampsia, maternal diabetes, early membrane rupture, ablatio placenta, blood transfusion, clinical sepsis, respiratory distress syndrome, necrotizing enterocolitis, intracranial hemorrhage, hydrocephalus and in-vitro fertilisation. The infants who were treated for threshold or high-risk prethreshold ROP were categorized in group 1 and those with APROP were in group 2. Results: Of the 127 infants with a mean gestational age of 27.4±2.2 weeks and a birthweight of 991.7±277.4 grams, 101 (79.5%) were classified in group 1 and 26 (20.5%) in group 2. Gestational age, birthweight, APGAR 1 and 5 scores were lower; and the need for blood transfusion, respiratory distress syndrome and clinical sepsis frequencies were higher for the infants with APROP. These differences were statistically significant.Conclusion: Small gestational age and low birthweight are most significant risk factors for APROP. It is difficult to decide whether other statistically significant risk factors including APGAR 1 and 5 scores, need for blood transfusion, respiratory distress syndrome and clinical sepsis are independent risk factors or accompanying diseases related to prematurity

Özet

Amaç: Prematüre retinopatisi nedeniyle lazer fotokoagülasyon uygulanan prematüre bebeklerin klinik ve demografik özellikleri incelenerek agresif posterior prematüre retinopatisi (APROP) gelişimi için risk oluşturan faktörlerin belirlenmesi amaçlanmıştır.Gereç ve Yöntem: Prematüre retinopatisi tanısıyla transpupiller diod lazer fotokoagülasyon uygulanan prematüre bebeklerin kayıtları retrospektif olarak incelenerek gestasyonel yaş, doğum ağırlığı, APGAR 1. ve 5. dakika skorları, doğum şekli, cinsiyet, çoğul gebelik, preeklampsi, maternal diyabet, erken membran rüptürü, ablatio plasenta, kan transfüzyonu ihtiyacı, klinik sepsis, respiratuar distres sendromu, nekrotizan enterokolit, intrakranial kanama, hidrosefali ve yardımcı üreme tekniklerinin kullanılması gibi maternal ve bebeğe ait muhtemel risk faktörleri kaydedildi. Eşik hastalık veya yüksek riskli eşik öncesi hastalık nedeniyle lazer tedavisi uygulanan bebekler Grup 1, APROP nedeniyle tedavi uygulanan bebekler ise Grup 2 olarak sınıflandırıldı.Bulgular: Ortalama gestasyonel yaşı 27.4±2.2 hafta ve ortalama doğum ağırlığı 991.7±277.4 gr olan 127 hastadan 101'inin (%79.5) Grup 1, 26'sının (%20.5) ise Grup 2'de yer aldığı izlendi. APROP nedeniyle lazer tedavisi uygulanan bebeklerin gestasyonel yaş, doğum ağırlığı, APGAR 1. ve 5. dakika skorlarının daha düşük, respiratuar distres sendromu ve klinik sepsis sıklığı ile kan transfüzyonu ihtiyaçlarının da daha yüksek olduğu ve bu farkların istatistiksel olarak anlamlı olduğu izlendi.Sonuç: APROP gelişimi için bilinen en önemli risk faktörleri küçük gestasyonel yaş ve düşük doğum ağırlığıdır. İstatistiksel olarak anlamlı farklılık tespit edilen APGAR skorları, kan transfüzyonu ihtiyacı, respiratuar distres sendromu ve klinik sepsis sıklığı gibi diğer muhtemel risk faktörlerinin hastalık gelişimi için bağımsız risk faktörleri mi yoksa prematürite ile ilişkili eşlik eden faktörler mi olduğuna karar verebilmek güçtür

🔖

Cite This Article

ŞEKEROĞLU, M. A., HEKİMOĞLU, E., BAŞ, A. Y., DEMİREL, N. (2015). Risk Factors For Agressive Posterior Retinopathy of Prematurity. Retina-Vitreus, Cilt: 23 - Sayı: 3, 195–198. https://ajindex.com/articles/308024

References (13)

  1. Sommer A, Taylor HR, Ravilla TD, et al. Council of the American Oph- thalmological Society. Challenges of ophthalmic care in the developing world. JAMA Ophthalmol 2014;132:640-4.
  2. Quiram PA, Capone A Jr. Current understanding and management of retinopathy of prematurity. Curr Opin Ophthalmol 2007;18:228-34.
  3. Kychenthal A, Dorta P, Katz X. Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Retina 2006;26:11-5.
  4. Azuma N, Ito M, Yokoi T, et al. Visual outcomes after early vitreous surgery for aggressive posterior retinopathy of prematurity. JAMA Ophthalmol 2013;131:1309-13.
  5. Nishina S, Yokoi T, Yokoi T, et al. Effect of early vitreous surgery for aggressive posterior retinopathy of prematurity detected by fundus fluorescein angiography. Ophthalmology 2009;116:2442-7.
  6. Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603-15.
  7. Hardy RJ, Good WV, Dobson V, et al. Early Treatment for Retinopathy of Prematurity Cooperative Group. Multicenter trial of early treat- ment for retinopathy of prematurity: study design. Control Clin Trials 2004;25:311-25. Palmer EA. Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP). Doc Ophthalmol 1990;74:245-51. Fierson WM. American Academy of Pediatrics Section on Ophthalmo- logy; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189-95.
  8. Ugurbas SC, Gulcan H, Canan H, et al. Comparison of UK and US screening criteria for detection of retinopathy of prematurity in a deve- loping nation. J AAPOS 2010;14:506-10.
  9. Başmak H, Niyaz L, Sahin A, et al. Retinopathy of prematurity: scree- ning guidelines need to be reevaluated for developing countries. Eur J Ophthalmol 2010;20:752-5.
  10. Sanghi G, Dogra MR, Katoch D, et al. Aggressive posterior retinopathy of prematurity in infants >= 1500 g birth weight. Indian J Ophthalmol 2014;62:254-7.
  11. Shah PK, Narendran V, Kalpana N. Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed 2012;97:371-5.
  12. Miller MM, Revenis ME, Lai MM, et al. Risk and clinical course of re- tinopathy of prematurity in 78 infants of gestational age 22-25 weeks. J AAPOS 2014;18:266-70.
  13. Shin DH, Kong M, Kim SJ,